share_log
Breakings ·  Sep 17 19:00
Boston Scientific Receives FDA Approval for Expanded Indication of Ingevity™+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch Area
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment